[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360244-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360244-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cost-effectiveness-and-budget-impact-of-a-fecal-immunochemical-testbased-colorectal-cancer-screening-program-in-a-cancer-center","Cost-effectiveness and budget impact of a fecal immunochemical test–based colorectal cancer screening program in a cancer center","","Colorectal cancer screening lowers cancer-specific mortality and is broadly recommended internationally, with fecal immunochemical testing (FIT) favored for population screening. Local evidence is limited, and implementing a FIT-based program may demand substantial resources. This study assessed cost-effectiveness and budget impact for introducing a FIT-based CRC screening program for insured beneficiaries at the Fundación Arturo López Pérez (FALP) Cancer Center. A Markov model estimated life-years gained, costs, ICER, and budget impact under base-case and co-payment scenarios.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cost-effectiveness-and-budget-impact-of-a-fecal-immunochemical-testbased-colorectal-cancer-screening-program-in-a-cancer-center/360244/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cost-effectiveness-and-budget-impact-of-a-fecal-immunochemical-testbased-colorectal-cancer-screening-program-in-a-cancer-center/360244.png","ImageObject",300,407,{"name":42,"@type":43},"Cart","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study evaluate regarding CRC screening at the FALP Cancer Center?","Question",{"text":63,"@type":64},"It evaluates both the cost-effectiveness and the budget impact of introducing a FIT-based colorectal cancer screening program for the insured population at the FALP Cancer Center.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the screening program modeled and compared?",{"text":68,"@type":64},"A Markov model compared the FIT screening program versus no screening, estimating expected costs, life-years gained, incremental cost-effectiveness ratio (ICER), and budget impact.",{"name":70,"@type":61,"acceptedAnswer":71},"What factors most influenced the cost-effectiveness results?",{"text":72,"@type":64},"FIT adherence and FIT positivity rate had the greatest influence on the cost-effectiveness outcomes, while co-payment scenarios reduced budget impact and improved affordability.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360244,1790194098,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":118,"preview_page_count":33,"preview_urls":144},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Muñoz-Montecinos etal. BMC Health Services Research (2026) 26:752 BMC Health Services Research  \n[https://doi.org/10.1186/s12913-026-14524-z](https://doi.org/10.1186/s12913-026-14524-z)  \nRESEARCH Open Access  \nCost-effectiveness and budget impact of a  fecal immunochemical test–based colorectal cancer screening program in a cancer center  \nCarlos Muñoz-Montecinos1, Camila Quirland1,2, Felipe Maza1, Carlos Barrientos3, Cristian Ayala4 and Catalina González-Browne1*  \nAbstract  \nBackground Colorectal cancer (CRC) screening reduces cancer-specific mortality and is widely recommended by international agencies. The fecal immunochemical test (FIT) is the preferred strategy for population-based screening. Although FIT-based screening is considered cost-effective internationally, no local evidence is available, and implementing such a program may require substantial resources. This study evaluated the cost-effectiveness and budget impact (BI) of introducing a FIT-based CRC screening program for the insured population of the Fundación Arturo López Pérez (FALP) Cancer Center.  \nMethods A Markov model was developed to assess the cost-effectiveness of the FIT screening program compared with no screening. Healthy beneficiaries aged 50–69 years were invited to undergo FIT every two years. Expected costs, life-years gained (LYG), and the incremental cost-effectiveness ratio (ICER) were estimated, along with the BI. Deterministic sensitivity analyses were performed, and co-payment scenarios involving out-of-pocket expenses were also explored.  \nResults The FIT-based CRC screening program was cost-effective across all scenarios analyzed, and even in a  \nco-payment scenario it was dominant over no screening. FIT adherence and FIT positivity rate had the greatest influence on cost-effectiveness outcomes. Although the ICER indicated a favorable cost-effectiveness profile, BI estimates for the base-case scenario highlighted the substantial financial burden of implementing the program.  \nCo-payment scenarios markedly reduced BI, making the program more affordable.  \nConclusions FIT-based CRC screening is a cost-effective strategy for the FALP-insured population. However, its significant budgetary impact may hinder implementation. Shared funding mechanisms could mitigate these financial barriers and enhance program feasibility.  \nKeywords Colorectal cancer screening, Cost-effectiveness, FIT, Budget impact  \n*Correspondence:  \nCatalina González-Browne  \n[catalina.gonzalez@falp.org](catalina.gonzalez@falp.org)  \n1Health Technology Assessment Unit, Cancer Research and Innovation Center, Fundación Arturo López Pérez (FALP) Cancer Center, Santiago, Chile  \n2Department of Pediatrics, Obstetrics and Gynecology and Preventive Medicine and Public Health, Universitat Autonoma de Barcelona, Barcelona, Spain  \n3Endoscopy Unit, Fundación Arturo López Pérez (FALP) Cancer Center, Santiago, Chile  \n4Executive Management, Fundación Arturo López Pérez (FALP) Cancer Center, Santiago, Chile  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit ","cbCaistQDqWKjaCb","https://ap.wps.com/l/cbCaistQDqWKjaCb","pdf",926141,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Burden and suitability for screening\n## Evidence for colonoscopy and FIT\n## Importance of budget impact and resource modeling","[{\"question\":\"What does the study evaluate regarding CRC screening at the FALP Cancer Center?\",\"answer\":\"It evaluates both the cost-effectiveness and the budget impact of introducing a FIT-based colorectal cancer screening program for the insured population at the FALP Cancer Center.\"},{\"question\":\"How was the screening program modeled and compared?\",\"answer\":\"A Markov model compared the FIT screening program versus no screening, estimating expected costs, life-years gained, incremental cost-effectiveness ratio (ICER), and budget impact.\"},{\"question\":\"What factors most influenced the cost-effectiveness results?\",\"answer\":\"FIT adherence and FIT positivity rate had the greatest influence on the cost-effectiveness outcomes, while co-payment scenarios reduced budget impact and improved affordability.\"}]","Cost-effectiveness and budget impact of a fecal immunochemical test–based colorectal cancer screening program in a cancer center | PDF",1790139200,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7e501ee6946e9fc694ccfe788eb9224.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6509f7ec913196ec92a6f47ad1d30613.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8518bfec48acb121d18d9494d34034f3.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1337c54e0f5dcd95d0951760d69e699.webp",980,1306]